- Home
- CAPR vs MVST Comparison
CAPR vs MVST Comparison
Compare CAPR & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- MVST
- Stock Information
- Founded
- CAPR 2005
- MVST 2006
- Country
- CAPR United States
- MVST United States
- Employees
- CAPR N/A
- MVST N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- MVST Industrial Machinery/Components
- Sector
- CAPR Health Care
- MVST Miscellaneous
- Exchange
- CAPR Nasdaq
- MVST Nasdaq
- Market Cap
- CAPR 578.4M
- MVST 676.9M
- IPO Year
- CAPR N/A
- MVST N/A
- Fundamental
- Price
- CAPR $15.00
- MVST $1.95
- Analyst Decision
- CAPR Strong Buy
- MVST Buy
- Analyst Count
- CAPR 7
- MVST 3
- Target Price
- CAPR $39.29
- MVST $3.33
- AVG Volume (30 Days)
- CAPR 902.1K
- MVST 7.6M
- Earning Date
- CAPR 03-03-2025
- MVST 03-31-2025
- Dividend Yield
- CAPR N/A
- MVST N/A
- EPS Growth
- CAPR N/A
- MVST N/A
- EPS
- CAPR N/A
- MVST N/A
- Revenue
- CAPR $23,228,045.00
- MVST $370,989,000.00
- Revenue This Year
- CAPR N/A
- MVST $19.19
- Revenue Next Year
- CAPR $74.85
- MVST $29.35
- P/E Ratio
- CAPR N/A
- MVST N/A
- Revenue Growth
- CAPR 65.33
- MVST 39.03
- 52 Week Low
- CAPR $3.52
- MVST $0.15
- 52 Week High
- CAPR $23.40
- MVST $2.87
- Technical
- Relative Strength Index (RSI)
- CAPR 52.56
- MVST 51.31
- Support Level
- CAPR $14.28
- MVST $1.55
- Resistance Level
- CAPR $16.47
- MVST $2.42
- Average True Range (ATR)
- CAPR 1.00
- MVST 0.20
- MACD
- CAPR 0.07
- MVST 0.03
- Stochastic Oscillator
- CAPR 55.05
- MVST 55.24
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.